Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cpi-613 (2 trials)
docetaxel (taxotere) (1 trial)
estramustine (emcyt) (1 trial)
gemcitabine (gemzar) (1 trial)
thalidomide (Thalomid) (1 trial)
fulvestrant (faslodex) (1 trial)
gedatolisib (1 trial)
goserelin (zoladex) (1 trial)
palbociclib (ibrance) (1 trial)
Breast Neoplasms (Phase 1)
Carcinoma (Phase 2)
Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (4 total)
Trial APIs (9 total)